Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

NCT00083564 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

240

Enrollment

INDUSTRY

Sponsor class

Stopped For business reasons

Conditions

Multiple Myeloma

Interventions

DRUG: STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP)

Sponsor

Poniard Pharmaceuticals